| Patents for C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (9,848) |
|---|
| 04/01/2008 | US7351719 Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds |
| 04/01/2008 | CA2272361C Polyether-modified polyisocyanate mixtures having improved dispersibility in water |
| 03/25/2008 | US7348456 Antagonists and/or inverse agonists of the Cannabinoid-1 receptor; useful in treatment of central nervous system disorders, psychological disorders, multiple sclerosis, as antiinflammatory agents |
| 03/25/2008 | US7348354 Cyclohexylurea compounds |
| 03/25/2008 | US7348328 MCH antagonists for the treatment of obesity |
| 03/25/2008 | CA2386420C Modifier for devulcanization of cured elastomers, mainly vulcanized rubber and method for devulcanization by means of this modifier |
| 03/20/2008 | WO2008031755A1 Process for preparing isocyanates |
| 03/19/2008 | EP1900723A1 New naphthalene derivatives, method of preparing same and pharmaceutical compositions containing them |
| 03/19/2008 | EP1899299A2 C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 03/19/2008 | CN101146765A Tetrahydronaphthalene derivatives, method for the production and the use thereof in the form of antiphlogistics |
| 03/19/2008 | CN101146760A Intermediate in production of [2-(3,3,5,5-tetramethylcyclohexyl)phenyl]piperazine compound |
| 03/18/2008 | US7345064 5-(4-pyridyl)valeric acid N-[2-(1-adamantyl)ethyl]-N-pentylamide; Autoimmune diseases such as rheumatoid arthritis, allergy and diabetes |
| 03/13/2008 | US20080064717 Type 2 diabetes, obesity, elevated plasma triglycerides, metabolic syndrome, non-alcoholic steatohepatitis, and non-alcoholic fatty liver disease; N-(3-chlorophenyl)-N'-(4'-{(R)-hydroxy[(1R,2R)-2-(hydroxymethyl)cyclopentyl]methyl}-1,1'-biphenyl-4-yl)urea |
| 03/13/2008 | US20080064687 Vanilloid receptor modulators; analgesic, antiinflammatory and antiulcer effects; such as 1-(1H-indol-5-ylmethyl)-3-phenethylthiourea |
| 03/12/2008 | CN101142174A Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same |
| 03/12/2008 | CN100374414C Naphthurea composition for preparation of carrier generation materials and process for preparing same |
| 03/11/2008 | CA2174194C Urethane-free, diphenylmethane diisocyanate prepolymers and process for their production and use |
| 03/06/2008 | WO2007133531A3 Hydrophilic stain release agents |
| 03/06/2008 | US20080058377 N-(7-hydroxy-5,6,7,8-tetrahydronaphthalen-2-yl)-N'-[4-(trifluoromethyl)benzyl] urea; antiinflammatory agent: asthma or COPD, analgesic: neuralgia, neuropathies, algesia, nerve injury, ischemia, neurodegeneration, or stroke; urological diseases: urinary incontinence or overactive bladder |
| 03/06/2008 | US20080058333 Carbamates such as (1-benzylcyclohexyl)methyl(1S)-5-[(4-morpholinylcarbonyl)amino]-1-(oxo([(1R)-1-phenylethyl]amino)acetyl)pentylcarbamate; osteoporosis |
| 03/06/2008 | US20080058314 Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 03/05/2008 | EP1893668A1 N-(2-hydroxyalkanoyl) -n,n'-dialkylureas and a process for their preparation |
| 03/05/2008 | EP1893563A1 Production of n-aryl carbamates and n-aryl isocyanates |
| 03/04/2008 | US7338945 (1R,4S) or (1S,4R)-1-Amino-4-(hydroxymethyl)-2-cyclopentene D- or L-hydrogen tartrate intermediates |
| 02/28/2008 | WO2008022938A1 Di-aromatic substituted amides as inhibitors for glyt1 |
| 02/28/2008 | US20080051523 Low-cure powder coatings and methods for using the same |
| 02/28/2008 | CA2661459A1 Di-aromatic substituted amides as inhibitors for glyt1 |
| 02/27/2008 | EP1892245A2 Antineoplastic compounds and pharmaceutical compositions thereof |
| 02/27/2008 | EP1891022A1 Photochemical crosslinkers for polymer coatings and substrate tie-layer |
| 02/27/2008 | CN101133060A Enzyme inhibitors |
| 02/27/2008 | CN101133019A Derivatives of aminobutanoic acid inhibiting cpt |
| 02/26/2008 | US7335687 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, mycoses, gallstones, hyperproliferative disorders, impaired glucose tolerance, or diabetes; aminocyclohexanol derivatives; e.g. N-(4-(4-[ethyl-(2-hydroxy-ethyl)-amino]-but-1-ynyl)-cyclohexyl)-N-methyl-4-trifluoromethyl-benzenesulfonamide |
| 02/21/2008 | US20080045546 Tetradydro-Naphthalene And Urea Derivatives |
| 02/20/2008 | EP1888514A1 Salts of substituted allophanates and their use in drugs |
| 02/20/2008 | EP1354871B1 Biphenyl derivatives |
| 02/20/2008 | CN100369893C Production of o-chlor-benzoylurea from tobacco stalks |
| 02/20/2008 | CN100369888C N-alkanoylphenylalanine derivatives |
| 02/19/2008 | US7332631 Fc receptor modulating compounds and compositions |
| 02/19/2008 | US7332553 Functional monomers for molecular recognition and catalysis |
| 02/19/2008 | US7332529 Thermoreversible organogelators, compositions and methods of making thereof |
| 02/14/2008 | WO2007119042A3 Process for the treatment of a product stream |
| 02/14/2008 | US20080039402 Peptides and Peptidomimetics Binding to Cd23 |
| 02/13/2008 | EP1885691A1 C5a receptor antagonists |
| 02/13/2008 | EP1885684A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta-2 adrenergic receptor |
| 02/13/2008 | EP1432677B1 Novel urea oligomers, the preparation method thereof and pharmaceutical compositions containing same |
| 02/13/2008 | EP1404650B1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments |
| 02/13/2008 | CN100368454C Polymeric allophanate of methylene diphenyl diisocyanate and its prepolymer and their preparation method |
| 02/13/2008 | CN100368391C Crotonylidene diurea production method |
| 02/12/2008 | US7329681 Inhibitors of IMPDH enzyme |
| 02/07/2008 | WO2008015081A1 Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as cpt-inhibitors |
| 02/07/2008 | US20080033015 Histone Deacetylase Inhibitors |
| 02/07/2008 | US20080032979 Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinease Inhibitors |
| 02/07/2008 | US20080032978 Soluble epoxide hydrolase inhibitors |
| 02/07/2008 | CA2658797A1 Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as cpt-inhibitors |
| 02/06/2008 | EP1324980B1 Citrullimycines, a process for their production and their use as pharmaceuticals |
| 02/06/2008 | CN100366606C New phenylamidine derivatives process for preparing the same and their use as medicaments |
| 02/06/2008 | CN100366605C Compounds to treat alzheimer's disease |
| 02/05/2008 | US7326746 Curable electron donor compositions |
| 02/05/2008 | US7326696 Amino-methyl substituted tetracycline compounds |
| 01/31/2008 | US20080027061 omega-Carboxy Aryl Substituted Diphenyl Ureas As p38 Kinase Inhibitors |
| 01/31/2008 | DE19525235B4 Harnstoff-Modifiziertes Carbodiimid und Verfahren zur Herstellung desselben Of the same urea-modified carbodiimide, and process for preparing |
| 01/30/2008 | CN101115713A HIV protease inhibitors |
| 01/29/2008 | US7323532 With activated, radiation-curable double bonds and can optionally also cure thermally, and low-viscosity polyisocyanate mixtures or secondary products thereof and their use in coating compounds |
| 01/29/2008 | US7323496 Compounds for treatment of inflammation, diabetes and related disorders |
| 01/24/2008 | WO2007137103A3 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme |
| 01/23/2008 | EP1879895A1 Enzyme inhibitors |
| 01/23/2008 | EP1879858A2 Processes for preparing biaryl ureas and analogs thereof |
| 01/23/2008 | CN101108813A Method of manufacturing 1-(2-methoxyphenyl)-3-naphthyl group-2-urea |
| 01/23/2008 | CN100363338C Polyisocyanate containing acyl urea group, its producing process and its application |
| 01/22/2008 | US7321001 carboxylic acid derivatives which modulate the function and/or expression of proteins involved in atopic diseases, inflammatory conditions and cancer |
| 01/17/2008 | WO2008006812A1 Method for obtaining symmetrical n,n'-disubstituted urea |
| 01/17/2008 | WO2008006625A2 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor |
| 01/17/2008 | US20080015227 Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme |
| 01/17/2008 | US20080015169 Amino-methyl substituted tetracycline compounds |
| 01/17/2008 | CA2658394A1 Substituted acylanilides and methods of use thereof |
| 01/17/2008 | CA2657350A1 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor |
| 01/16/2008 | EP1458684B1 Therapeutic heterocycles as bradykinin b2 receptor antagonists |
| 01/10/2008 | WO2007137107A3 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme |
| 01/10/2008 | WO2007093292A3 Insecticidal substituted amino heterocyclic and heteroaryl derivatives |
| 01/09/2008 | EP1876171A1 Apparatus for urea synthesis and method of improving the same |
| 01/09/2008 | EP1176956B1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 01/09/2008 | EP1129064B1 Transfection reagents |
| 01/09/2008 | CN100360507C Inhibition of raf kinase using substituted heterocyclic ureas |
| 01/08/2008 | US7317028 Antitumor agents; autoimmune disease; skin disorders; anticancer agents |
| 01/08/2008 | US7317019 N-alkylated diaminopropane derivatives as modulators of chemokine receptor activity |
| 01/08/2008 | CA2408602C Phenylglycine derivatives |
| 01/08/2008 | CA2334298C Neuropeptide y5 receptor antagonists |
| 01/03/2008 | WO2008000969A1 Novel naphthalenic derivatives, method for the preparation thereof, and pharmaceutical compositions containing same |
| 01/03/2008 | US20080004455 Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same |
| 01/03/2008 | US20080003290 Phenethanolamine Derivatives for Treatment of Respiratory Diseases |
| 01/02/2008 | CN101098852A Glycogen phosphorylase inhibitor compounds and pharmaceutical compositions thereof |
| 01/01/2008 | US7314888 2-{5-[(2,4-diisobutoxyphenyl)(hydroxy)methyl]-2-isobutoxyphenyl}-acetic acid; inhibits the activity of transcription factor AP-1 |
| 12/27/2007 | US20070299263 Hydroxy Alkyl Amines |
| 12/27/2007 | US20070299033 stavudine:melamine co-crystal or stavudine:2-aminopyridine co-crystal; therapeutics; shelf-life, bioavailability |
| 12/26/2007 | EP1868986A1 Tetrahydronaphthalene derivatives method for the production and the use thereof in the form of antiphlogistics |
| 12/26/2007 | CN100357268C Process for synthesizing sec-butyl urea |
| 12/25/2007 | US7312241 Diphenylethylene compounds and uses thereof |
| 12/21/2007 | WO2006122782A8 N-(2-hydroxyalkanoyl) -n,n'-dialkylureas and a process for their preparation |
| 12/20/2007 | US20070293529 Tetrasubstituted ureas as modulators of 11-beta hydroxyl steroid dehydrogenase type 1 |
| 12/19/2007 | EP1867633A1 Polyamine analogues as therapeutic and diagnostic agents |